Studies don't back this.
We reviewed the trials we hold for heart. Nattokinase's results were not strong enough to credit. A small short-term blood-pressure signal exists, but it is not enough to credit a product with: the review is unclear about which doses produced it, and it did not measure heart attacks, strokes or clots. It does not show heart protection or justify self-treatment.
See the evidence behind this answer in the complete report, including what was tested, the dose and preparation used, who took part, and funding information where available.
